Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
Status:
Recruiting
Trial end date:
2025-10-19
Target enrollment:
Participant gender:
Summary
The rationale for this study is to investigate whether in psoriatic arthritis (PsA) patients
in stable remission a reduction or complete discontinuation of immunosuppressive therapy can
be achieved in a treat-to-target approach while maintaining in remission. Due to the lack of
reliable data that answers the question of how to safely reduce medication in which patients,
this study will test a pragmatic treatment algorithm that can be applied in clinical practice
and that offers a gradual reduction with escape strategies in order to facilitate the
maintenance of remission.